Program for Thursday, April 27th: Talk View

PROGRAM FOR THURSDAY, APRIL 27TH: TALK VIEW

Days:

previous day

next day

all days

View: with abstracts session overview

7:00

7:30

8:00

8:30

9:00

9:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

20:00

20:30

21:00

21:30

22:00

22:30

23:00

07:00-08:30 Session 11

08:00-19:00 Session 12

08:30-09:00

How cell therapy has been implemented in Europe, evolution from classical to new therapies.

Florent Malard

09:00-09:30

The graft-versus-host disease (GVHD): Novel developments in GVHD therapy.

Robert Zeiser

09:30-10:00

Advancing T cell therapies (CAR T-cell immunotherapies).

Carole Guillonneau

10:30-11:00

Telemedicine in renal transplantation: Innovations for 2023 and beyond.

Martijn van den Hoogen

11:00-11:30

Generation Of Human Induced Pluripotent Stem Cells From Haplo-Selected Cord Blood Samples

Begoña Aran

11:30-12:00

Temporal regulation of transgene expression controlled by amino acid availability in human T cells.

Paul-Olivier Rouzaire

10:30-11:00

The ESOT initiative to build pan-European registries in SOT: why? how? where are we standing?

Gabriel Oniscu

11:00-11:30

The use of genomic to assist decision-making in transplantation.

Sophie Limou

11:30-12:00

Refining the diagnosis of rejection by artificial intelligence.

Jasper Callemeyn

10:30-10:40

From global population genetic profiles to detailed individual molecular variation in humans and chimpanzees: a new turn in our understanding of MHC diversity and

Di et.al

10:40-10:50

CREATING FULLY REPRESENTATIVE MHC REFERENCE HAPLOTYPES

Pollock et.al

10:50-11:00

MICA Copy Number Variations are the Result of Numerous Independent Non-Allelic Homologous Recombination

Klussmeier, Putke, Klasberg, Kohler, Schöfl, Schmidt, Roers, Lange

11:00-11:10

High Frequency of MICA Gene Deletion Haplotypes in Several Non-European Populations

Anja Klussmeier, Jürgen Sauter, Alexander H. Schmidt, Vinzenz Lange

11:10-11:20

Telomeres and ageing and their relation with HLA – results from the project “Immunogenetics of Ageing” within 18th

Bogunia-Kubik et.al

11:20-11:30

Classical HLA alleles and long-range haplotypes are under rapid selection among admixed populations

Luo et.al

11:30-11:40

Human Leukocyte Antigens (HLA) evolutionary divergence (HED) calculator

Bruno Lima

11:40-11:50

A high-throughput approach to the MHC assembly challenge in disease association

Wade, Augusto, Kizer, Yusufali, Boquett, Callier, Oksenberg, Hollenbach

10:30-10:40

The beneficial impact of HLA-E mismatching for patients receiving a less than 10/10 HLA matched hematopoietic cell

J.A. Lucas, R.M. Szydlo, S. Hewerdine, S.G. Marsh, N.P. Mayor

10:40-10:50

Clinical relevance of cell-free DNA quantification and qualification during the first month after lung

Pedini et.al

10:50-11:00

Full-gene sequence characterisation of HLA-DMA, -DMB, -DOA, and -DOB in a panel of International HLA and Immunogenetics Workshop cell

M. Tierney, T.T. Turner, G. Benitez, D. Barker, N. Mayor, S. Marsh

11:00-11:10

Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10

Stefan Schaub

11:10-11:20

Characterization of chimpanzee KIR haplotype organizations using Cas9 enrichment and Oxford Nanopore

Corrine Heijmans, Jesse Bruijnesteijn, Natasja G. de Groot, Ronald E. Bontrop

11:20-11:30

TXMatching – a novel software for kidney paired donations

Röder et.al

11:30-11:40

HLA loss detection by NGS using STR markers within the MHC region on chromosome 6

Geerligs, Rond, Dadkhodaie, Keja, Penning, van de Pasch, van Wageningen

11:40-11:50

Assessment of a Universal Blood Donor Genotyping Platform

Brown et.al

12:00-14:30 EFI Executive Committee and Coordinators meeting

12:00-14:00 SHLARC Consortium meeting

12:10-13:10 Luncheon Industry Symposium: CareDx

13:20-14:20 Luncheon Industry Symposium: Immucor

13:30-14:30 ETHIQ Diploma meeting

14:30-15:00

Genetic diversity in metropolitan France at the beginning of the 20th century: the POPGEN project

Emmanuelle Génin

15:00-15:30

HLA genetic diversity and the challenges for analyzing highly polymorphic and repetitive genes.

Erick Castelli

14:30-15:00

Regulatory T cells, translation to the clinic.

Alberto Sanchez Fueyo

15:00-15:30

Regulatory B cells, where we are?

Mübeccel Akdis

15:30-16:00

B cell functional subsets from autoimmunity to transplantation

Sophie Hillion

14:30-14:40

Chromosomal rearrangements in the KIR gene cluster as evolutionary strategy to protect against evading

J. Bruijnesteijn, M. van der Wiel, N. de Groot, N. de Groot, R. Bontrop

14:40-14:50

Variegated expression of KIR regulated by conserved and diverged promoter regions in humans and

M. van der Wiel, J. Bruijnesteijn, N. de Groot, N. de Groot, R. Bontrop

14:50-15:00

Polymorphism of HLA and KIR affects severity of COVID-19 by shaping innate and adaptive immunity to

Farias et.al

15:00-15:10

The role of natural killer cells in recurrent pregnancy loss: evaluation of natural killer cell

Amber Lombardi, Denise Habets, Marc Spaanderman, Salwan Al-Nasiry, Lotte Wieten

15:10-15:20

KIR2DL2/C1: a potential predictive immunogenetic marker to COVID-19 severity in Spanish patients

Niño Ramirez et.al

15:20-15:30

Nanopores may replace SMRT reads for dual redundant reference sequencing (DR2S): Characterization of more than 600 novel KIR

K. Putke, S. Klasberg, G. Girke, A.H. Schmidt, A. Klussmeier, V. Lange

15:30-15:40

Natural killer cell receptor variation is associated with more aggressive subtypes of breast cancer

L. Amorim, M. Beltrame, E. Ribeiro, J. Hollenbach, D. Augusto

15:40-15:50

HLA class I epitope and KIR diversities in multiple myeloma

N. Beelen, S. Molenbroeck, L. Groeneveld, C. Voorter, L. Wieten

14:30-14:40

Immunogenomic exploration in a large kidney transplantation genetic cohort reveals a kidney graft failure association with HLA-B*40:01 and KIRD2L2/HLA-C2

Limou, Baron, Tissafi-Idrissi, Mauduit, Durand, Blancho, Giral, Douillard, Vince

14:40-14:50

In the era of precision medicine: lncRNAs as probable biomarkers to predict allograft rejection

Kanga, Sharma, Agarwal, Suravajhala, Baranwal, Bagchi, Sharma

14:50-15:00

Gene expression profiles in 3 month biopsies associate with progression to kidney transplant rejection before detection of histological

Duygu, Groeneweg, Adul-Hamid, van Kempen, Gelens, Christiaans, Voorter, Wieten

15:00-15:10

Precision medicine in liver transplant recipients: donor cell-free DNA as an early marker of post-transplant hepatic

Sorbini et.al

15:10-15:20

Acute and chronic rejection monitoring of pediatric heart transplant recipients through a ddPCR assay based on HLA-DRB1

Sorbini et.al

15:20-15:30

Genome-wide survival study identifies a novel association between donor genotype and antibody-mediated kidney graft

Mauduit et.al

15:30-15:40

The number of donor HLA-derived T-cell epitopes available for indirect antigen presentation determines the risk for vascular rejection after kidney

Michiel Betjes, Emma Peereboom, Henny Otten, Eric Spierings

15:40-15:50

Impact of HLA diversity on humoral response to SARS-Cov-2 and HBV vaccines in liver transplant

C. Feray, V. Allain, J.-L. Taupin, C. Desterke, D. Samuel, S. Caillat-Zucman

16:30-17:00

HLA and individual response to infection and vaccination

Julian Knight

17:00-17:30

Gene, transcript and proteins to understand immune diseases.

Patrick Sulem

17:30-18:00

Illuminating the dark corners of the immune system: novel approaches for characterizing haplotype diversity in the T cell receptor and immunoglobulin

Corey T Watson

18:00-20:00 Poster Viewing Session

19:00-23:00 Ceppellini (by invitation only)

19:00-23:00 Speakers dinner (by invitation only)

10:00-10:30 Coffee Break

12:00-12:10 Coffee Break

14:20-14:30 Coffee Break

16:00-16:30 Coffee Break